1.25 ? 0.005 (0.40%)
Volume: 966,738 @09/22/21 7:28:29 PM EDT
Bid Ask Day's Range
1.23 1.25 1.225 - 1.26
ADMA Detailed Quote
Recent ADMA News
- ADMA Biologics Set to Join S&P SmallCap 600 Index • GlobeNewswire Inc. • 09/17/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 01:00:24 AM
- ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 01:00:31 AM
- Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 • PR Newswire (US) • 09/06/2024 10:43:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2024 01:05:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2024 01:02:08 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/31/2024 01:00:10 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 01:26:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 01:22:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 01:00:24 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/27/2024 01:28:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 01:05:31 PM
- ADMA Biologics Announces Partial Paydown of Revolving Credit Facility • GlobeNewswire Inc. • 08/14/2024 12:59:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 09:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:34 PM
- ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/27/2024 01:10:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/27/2024 01:05:33 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/27/2024 01:00:10 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM